- Home
- TMO vs AZN Comparison
TMO vs AZN Comparison
Compare TMO & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- AZN
- Stock Information
- Founded
- TMO 1956
- AZN 1992
- Country
- TMO United States
- AZN United Kingdom
- Employees
- TMO N/A
- AZN N/A
- Industry
- TMO Industrial Machinery/Components
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- TMO Industrials
- AZN Health Care
- Exchange
- TMO Nasdaq
- AZN Nasdaq
- Market Cap
- TMO 203.5B
- AZN 216.6B
- IPO Year
- TMO N/A
- AZN 1993
- Fundamental
- Price
- TMO $582.40
- AZN $69.87
- Analyst Decision
- TMO Strong Buy
- AZN Buy
- Analyst Count
- TMO 20
- AZN 8
- Target Price
- TMO $656.65
- AZN $89.75
- AVG Volume (30 Days)
- TMO 2.1M
- AZN 4.9M
- Earning Date
- TMO 01-30-2025
- AZN 02-06-2025
- Dividend Yield
- TMO 0.27%
- AZN 2.13%
- EPS Growth
- TMO 6.99
- AZN 9.79
- EPS
- TMO 16.53
- AZN 4.15
- Revenue
- TMO $42,879,000,000.00
- AZN $51,206,000,000.00
- Revenue This Year
- TMO $5.38
- AZN $19.21
- Revenue Next Year
- TMO $6.97
- AZN $6.95
- P/E Ratio
- TMO $35.10
- AZN $33.43
- Revenue Growth
- TMO 0.05
- AZN 13.81
- 52 Week Low
- TMO $493.30
- AZN $60.47
- 52 Week High
- TMO $627.88
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- TMO 58.36
- AZN 58.29
- Support Level
- TMO $576.85
- AZN $68.76
- Resistance Level
- TMO $610.97
- AZN $71.55
- Average True Range (ATR)
- TMO 11.98
- AZN 0.85
- MACD
- TMO 0.51
- AZN 0.15
- Stochastic Oscillator
- TMO 55.73
- AZN 70.29
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.